Skip to main content
. 2020 Jan 29;99(3):1387–1394. doi: 10.1016/j.psj.2019.11.019

Table 4.

The effect of treatments on Salmonella enterica subsp. enterica serovar Infantis population (Log10 cfu*/g) of cecal content and liver tissue.

Treatments Age (D)
7 14 21
Cecum
 S 9.24 ± 0.20a 6.82 ± 0.35a 4.36 ± 0.15a
 SA 7.73 ± 0.89c 3.66 ± 0.37c 0.48 ± 0.24e
 SIPY 8.89 ± 0.57a,b 6.39 ± 0.32a 3.83 ± 0.22b,c
 SCIY 8.51 ± 0.83a,b 4.82 ± 0.28b 1.60 ± 0.27d
 SIWY 8.89 ± 0.50a,b 6.61 ± 0.45a 3.74 ± 0.45c
 SNIPY 9.10 ± 0.56a,b 6.86 ± 0.33a 4.23 ± 0.39a,b
 SNIWY 9.20 ± 0.37a,b 6.87 ± 0.41a 4.25 ± 0.28a,b
 C 0.0 ± 0.0d 0.0 ± 0.0d 0.0 ± 0.0f
P-value 0.0001 0.0001 0.0001
Treatments Liver
 S 5.39 ± 0.27a 3.85 ± 0.64a 1.74 ± 0.56a
 SA 2.47 ± 0.19c 0.08 ± 0.11c 0.0 ± 0.0b
 SIPY 5.07 ± 0.51a 3.43 ± 0.72a 1.6 ± 0.45a
 SCIY 3.46 ± 0.79b 1.47 ± 0.38b 0.0 ± 0.0b
 SIWY 5.21 ± 0.26a 3.68 ± 1.24a 1.54 ± 0.43a
 SNIPY 5.49 ± 0.27a 3.97 ± 0.71a 1.69 ± 0.48a
 SNIWY 5.13 ± 0.29a 3.78 ± 0.99a 1.71 ± 0.32a
 C 0.0 ± 0.0d 0.0 ± 0.0c 0.0 ± 0.0b
P-value 0.0001 0.0001 0.0001

a-bMeans within a column lacking a common superscripts differ (P < 0.01).

Abbreviations: S, Salmonella challenged groups; SA, Salmonella antibiotic; SIPY, Salmonella immune powdered yolk; SCIY, Salmonella capsulated immune yolk; SIWY, Salmonella immune water-soluble yolk fraction; SNIWY, Salmonella nonimmune water-soluble yolk fraction; NC, negative control.

*Log CFU SI per gram of cecal content and mixed liver tissue (n = 6).

Values represent the mean ± SD.